glutamine has been researched along with nystatin a1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Balaban, RS; Lynch, RM | 1 |
| Das, S; Prasad, R; Rao, TV | 1 |
1 review(s) available for glutamine and nystatin a1
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for glutamine and nystatin a1
| Article | Year |
|---|---|
Energy metabolism of renal cell lines, A6 and MDCK: regulation by Na-K-ATPase.
Topics: Adenosine Triphosphate; Animals; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Cell Line; Dogs; Energy Metabolism; Glucose; Glutamine; Glycolysis; Kidney; Nystatin; Ouabain; Oxidative Phosphorylation; Oxygen Consumption; Sodium-Potassium-Exchanging ATPase; Xenopus laevis | 1987 |
Effect of phospholipid enrichment on nystatin action: differences in antibiotic sensitivity between in vivo and in vitro conditions.
Topics: Biological Transport; Cell Membrane Permeability; Glutamine; Lipids; Liposomes; Lysine; Membrane Lipids; Nystatin; Phosphatidylcholines; Phosphatidylethanolamines; Saccharomyces cerevisiae | 1985 |